Back

Optimal antithrombotic strategy for patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention: updated meta-analysis of randomised controlled trials

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Becky Yi Wen Liao

Middlemore Hospital, Auckland (New Zealand)

238 More presentations in this session

Presentation thumbnail
Prevalence of thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries and cryptogenic stroke
Miss S. Kruchinova (Krasnodar, RU)
Abstract Slides
Presentation thumbnail
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
Doctor M. Centola (Desio, IT)
Abstract Slides
Presentation thumbnail
Clinical predictors and angiographic features of acute coronary syndromes caused by systemic embolism
Mr A. Jeronimo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Morphological characteristics of plaque erosion with noncritical coronary stenosis: an optical coherence tomography study
Doctor C. Fang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Metformin exerts cardioprotection via attenuating mitochondrial fission in cardiac ischaemia-reperfusion injury in rats
Doctor T. Clements (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Congress Presentation
Meta-analysis comparing impact of age, sex and renal function on the efficacy and safety of new oral anticoagulants vs. vitamin K antagonists for the treatment of acute venous thromboembolisms
28 August 2020
thumbnail
Congress Presentation
Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years?
28 August 2022
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources